Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Diana Y Y Chiu"'
Publikováno v:
PLoS ONE, Vol 13, Iss 5, p e0197400 (2018)
BACKGROUND:Proton pump inhibitors (PPIs) are one of the most widely prescribed medications across the world. PPIs have been associated with significant electrolyte abnormalities including hypomagnesaemia. We explored the prevalence of PPI associated
Externí odkaz:
https://doaj.org/article/1ea252c0ec04452699d5ccb09d86d4e4
Publikováno v:
Nephrology Dialysis Transplantation. 35
Background and Aims Cardiovascular disease is common in chronic and end stage kidney disease. Left ventricular hypertrophy (LVH) has been identified as contributor to cardiovascular risk in this population. The aim of the study was to assess whether
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::65f7e8b68560765c19d98e339f32aece
https://doi.org/10.1093/ndt/gfaa142.p1481
https://doi.org/10.1093/ndt/gfaa142.p1481
Publikováno v:
Kidney & Blood Pressure Research, Vol 43, Iss 6, Pp 1935-1942 (2018)
Background/Aims: Echocardiographic abnormalities of systolic function can be detected earlier with advancing echocardiographic technologies. Given the high prevalence of left ventricular hypertrophy in dialysis patients, we hypothesised that one such
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bc732b752628dd4da59633c3c06f7f5
https://pubmed.ncbi.nlm.nih.gov/30566951
https://pubmed.ncbi.nlm.nih.gov/30566951
Publikováno v:
Nature Reviews Nephrology. 11:207-220
Patients with chronic kidney disease have a high risk of developing cardiovascular disease but diagnosis of cardiovascular dysfunction in this population is complicated. In this Review, the authors describe cardiac imaging techniques that can be used
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ef21c8872710ba823b56a18319f41d4
https://doi.org/10.1038/nrneph.2014.243
https://doi.org/10.1038/nrneph.2014.243
Autor:
Philip A. Kalra, Shabeer Kolakkat, Smeeta Sinha, Diana Y. Y. Chiu, Elizabeth Lamerton, George Peebles, Sean Fenwick
Publikováno v:
Journal of Renal Care. 35:67-73
Background Low-molecular-weight iron dextran (CosmoFer) is the only form of parenteral iron that can be administered as a total dose infusion (TDI) in the United Kingdom (UK). This study aimed to evaluate the safety and efficacy of TDI CosmoFer in co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93f380c341df29d240516bfef66e62c1
https://doi.org/10.1111/j.1755-6686.2009.00099.x
https://doi.org/10.1111/j.1755-6686.2009.00099.x
Publikováno v:
American journal of kidney diseases : the official journal of the National Kidney Foundation. 64(5)
Patients with end-stage renal disease undergoing hemodialysis have high rates of morbidity and mortality. Cardiovascular disease accounts for almost half of this mortality, with the single most common cause being sudden cardiac death. Early detection
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8dca634ad3a5cfdac64a8e83f82aaff
https://pubmed.ncbi.nlm.nih.gov/24751169
https://pubmed.ncbi.nlm.nih.gov/24751169
Autor:
Philip A. Kalra, Christopher M. Ward, Donal O'Donoghue, Paul R. Kalra, Paul Atkinson, Diana Y. Y. Chiu, Robert N. Foley, Stephen Waldek, Raj Sharma, Mike C. Venning
Publikováno v:
International journal of cardiology. 146(2)
Background Coronary artery disease is a major cause of morbidity and mortality in renal transplant recipients, but there is no agreed screening protocol. The value of myocardial perfusion imaging (MPI) and coronary angiography (CA) in predicting futu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88bfa638889199fe118a6abe4dd664ad
https://pubmed.ncbi.nlm.nih.gov/19631398
https://pubmed.ncbi.nlm.nih.gov/19631398
Autor:
Diana Y. Y. Chiu, Janet Hegarty, Donal O'Donoghue, Anne M. Whiteside, Graeme Wood, Hari Mamtora, Stephen Waldek, Philip A. Kalra
Publikováno v:
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 22(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3377343421425798eb3f634bce3b998b
https://pubmed.ncbi.nlm.nih.gov/17259650
https://pubmed.ncbi.nlm.nih.gov/17259650
Autor:
Diana Y. Y. Chiu, Smeeta Sinha, Philip A. Kalra, Elizabeth Lamerton, Sean Fenwick, Shabeer Kolakkat, George Peebles
Publikováno v:
NDT Plus
Sir, Low-molecular-weight iron dextran (cosmoFer® (marketed as INFed® in the USA), Pharmacosmos, Denmark) is available as a total dose infusion (TDI) in the United Kingdom (UK). The use of TDI regimen enables patients to receive their iron dose in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7238a9b0b1637ee525f75279daf2de41
https://doi.org/10.1093/ndtplus/sfp073
https://doi.org/10.1093/ndtplus/sfp073